Early Phase 1 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older when you sign the consent form
- You must have been diagnosed with melanoma (confirmed by a tissue sample), from any location on the body or of unknown origin
- Your melanoma must have a specific gene change called a BRAFV600 mutation, and must be at an advanced stage (Stage III B/C/D or Stage IV)
- You must be well enough to carry out basic daily activities (your doctor will assess this using a standard scale)
- Your blood test results must show acceptable levels of red blood cells, platelets, liver function, and kidney function
- If you could become pregnant, you must have a negative pregnancy test and agree to use highly effective non-hormonal contraception during the trial
- If you are male, you must agree to use highly effective contraception during the trial
- You may have previously received certain immunotherapy treatments (anti-PD-1/PD-L1 or CTLA-4 inhibitors)
- People living with HIV may be eligible if they are on effective treatment and their virus levels are undetectable
- People with a history of hepatitis C may be eligible if they have been successfully treated and cured, or have undetectable virus levels if currently being treated
Who may not be able to join:
- You are not eligible if your melanoma got worse while you were actively taking BRAF or MEK inhibitor drugs (though progressing after stopping those drugs may be permitted)
- You cannot join if you previously had to stop taking the specific study drugs (encorafenib and/or binimetinib) due to serious side effects
- You cannot join if you have had major surgery or radiation treatment within the last 14 days, or have not yet recovered from those procedures
- You cannot join if you are unwilling to avoid grapefruit, pomegranates, star fruit, Seville oranges, or their juices during the study
- You cannot join if you have brain tumours that are unstable, causing symptoms, require steroid treatment, or have been treated with radiation within the last 28 days (confirm with trial site)
- You cannot join if you have certain serious heart problems, including severe heart failure, uncontrolled irregular heart rhythms, or an abnormal heart electrical reading above a certain level
- You cannot join if you have a known history of a blood clot in the eye (retinal vein occlusion)
- You cannot join if you are currently taking, or have recently taken within the past week, any medications, herbal supplements, or foods that are not permitted in this trial (confirm with trial site for the full list)
- You cannot join if you are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zeynep Eroglu, MD, Moffitt Cancer Center
Phone: 813-745-5938
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of Disease Relapse
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.